Search clinical trials for: Tivantinib
Total 30 results
-
Daiichi Sankyo, Inc.ICON Clinical Research; ArQule, Inc. (a wholly owned subsidiary of Merck Sharp...Completed
-
Daiichi Sankyo, Inc.TerminatedNon-CNS Germ Cell Tumors (Seminomas and Nonseminomas)United States, France, United Kingdom
-
Daiichi Sankyo, Inc.Medpace, Inc.CompletedCancer | Solid Tumor | Hepatic ImpairmentUnited States
-
Istituto Oncologico Veneto IRCCSTerminatedCarcinoma, Small CellItaly
-
Kyowa Kirin Co., Ltd.Completed
-
Daiichi Sankyo, Inc.Medpace, Inc.Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
National Cancer Institute (NCI)Completed
-
Armando Santoro, MDCompletedNonsquamous Nonsmall Cell Neoplasm of Lung | Malignant Pleural MesotheliomaItaly
-
Armando Santoro, MDCompletedColorectal Cancer Metastatic | C-met OverexpressionItaly
-
National Cancer Institute (NCI)TerminatedEpithelioid Mesothelioma | Sarcomatoid Mesothelioma | Stage IV Pleural Mesothelioma | Recurrent Malignant Mesothelioma | Stage II Pleural Mesothelioma | Stage III Pleural MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedChildhood Solid NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck CarcinomaUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
Daiichi Sankyo, Inc.CompletedMetastatic Colorectal CancerUnited States, Russian Federation, Germany, France, Italy
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.CompletedMalignant Solid Tumour | Gastroesophageal CancerUnited States
-
Immunovative Therapies, Ltd.Mirror Biologics, Inc.Recruiting
-
National Cancer Institute (NCI)CompletedAdult Solid NeoplasmUnited States
-
Xinchen WangTibet Autonomous Region People's HospitalCompletedSeptic Shock | Stress Response | Cerebral HemodynamicsChina
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedTivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsAdult Solid NeoplasmUnited States
-
Daiichi Sankyo, Inc.Medpace, Inc.Completed
-
National Cancer Institute (NCI)Completed